These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 19584439)
21. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease. Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017 [TBL] [Abstract][Full Text] [Related]
22. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model. Reilly JF; Games D; Rydel RE; Freedman S; Schenk D; Young WG; Morrison JH; Bloom FE Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4837-42. PubMed ID: 12697936 [TBL] [Abstract][Full Text] [Related]
23. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589 [TBL] [Abstract][Full Text] [Related]
24. L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutations. Willis M; Kaufmann WA; Wietzorrek G; Hutter-Paier B; Moosmang S; Humpel C; Hofmann F; Windisch M; Knaus HG; Marksteiner J J Alzheimers Dis; 2010; 20(4):1167-80. PubMed ID: 20413896 [TBL] [Abstract][Full Text] [Related]
25. Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice. Cruz NF; Ball KK; Dienel GA ASN Neuro; 2010 Aug; 2(4):e00041. PubMed ID: 20730033 [TBL] [Abstract][Full Text] [Related]
26. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease. Ceyzériat K; Ben Haim L; Denizot A; Pommier D; Matos M; Guillemaud O; Palomares MA; Abjean L; Petit F; Gipchtein P; Gaillard MC; Guillermier M; Bernier S; Gaudin M; Aurégan G; Joséphine C; Déchamps N; Veran J; Langlais V; Cambon K; Bemelmans AP; Baijer J; Bonvento G; Dhenain M; Deleuze JF; Oliet SHR; Brouillet E; Hantraye P; Carrillo-de Sauvage MA; Olaso R; Panatier A; Escartin C Acta Neuropathol Commun; 2018 Oct; 6(1):104. PubMed ID: 30322407 [TBL] [Abstract][Full Text] [Related]
28. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. Norris CM; Kadish I; Blalock EM; Chen KC; Thibault V; Porter NM; Landfield PW; Kraner SD J Neurosci; 2005 May; 25(18):4649-58. PubMed ID: 15872113 [TBL] [Abstract][Full Text] [Related]
29. Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease. Katsouri L; Birch AM; Renziehausen AWJ; Zach C; Aman Y; Steeds H; Bonsu A; Palmer EOC; Mirzaei N; Ries M; Sastre M Glia; 2020 May; 68(5):1017-1030. PubMed ID: 31799735 [TBL] [Abstract][Full Text] [Related]
30. Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease. Portal B; Södergren M; Parés I Borrell T; Giraud R; Metzendorf NG; Hultqvist G; Nilsson P; Lindskog M J Alzheimers Dis; 2024; 100(3):1017-1037. PubMed ID: 38995780 [TBL] [Abstract][Full Text] [Related]
31. Neuron-astrocyte signaling is preserved in the aging brain. Gómez-Gonzalo M; Martin-Fernandez M; Martínez-Murillo R; Mederos S; Hernández-Vivanco A; Jamison S; Fernandez AP; Serrano J; Calero P; Futch HS; Corpas R; Sanfeliu C; Perea G; Araque A Glia; 2017 Apr; 65(4):569-580. PubMed ID: 28130845 [TBL] [Abstract][Full Text] [Related]
32. Reactive astrocytes associated with plaques in TgCRND8 mouse brain and in human Alzheimer brain express phosphoprotein enriched in astrocytes (PEA-15). Thomason LA; Smithson LJ; Hazrati LN; McLaurin J; Kawaja MD FEBS Lett; 2013 Aug; 587(15):2448-54. PubMed ID: 23792157 [TBL] [Abstract][Full Text] [Related]
33. High potassium exposure reveals the altered ability of astrocytes to regulate their volume in the aged hippocampus of GFAP/EGFP mice. Kolenicova D; Tureckova J; Pukajova B; Harantova L; Kriska J; Kirdajova D; Vorisek I; Kamenicka M; Valihrach L; Androvic P; Kubista M; Vargova L; Anderova M Neurobiol Aging; 2020 Feb; 86():162-181. PubMed ID: 31757575 [TBL] [Abstract][Full Text] [Related]
34. Disease-associated astrocytes in Alzheimer's disease and aging. Habib N; McCabe C; Medina S; Varshavsky M; Kitsberg D; Dvir-Szternfeld R; Green G; Dionne D; Nguyen L; Marshall JL; Chen F; Zhang F; Kaplan T; Regev A; Schwartz M Nat Neurosci; 2020 Jun; 23(6):701-706. PubMed ID: 32341542 [TBL] [Abstract][Full Text] [Related]
35. Astrocytes in physiological aging and Alzheimer's disease. Rodríguez-Arellano JJ; Parpura V; Zorec R; Verkhratsky A Neuroscience; 2016 May; 323():170-82. PubMed ID: 25595973 [TBL] [Abstract][Full Text] [Related]
36. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Orre M; Kamphuis W; Osborn LM; Jansen AHP; Kooijman L; Bossers K; Hol EM Neurobiol Aging; 2014 Dec; 35(12):2746-2760. PubMed ID: 25002035 [TBL] [Abstract][Full Text] [Related]
37. Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. Rossi D; Brambilla L; Valori CF; Crugnola A; Giaccone G; Capobianco R; Mangieri M; Kingston AE; Bloc A; Bezzi P; Volterra A J Biol Chem; 2005 Dec; 280(51):42088-96. PubMed ID: 16253995 [TBL] [Abstract][Full Text] [Related]